Medizinische Universität Graz - Research portal
Affiliated Centres
SCI/PUBMED listed | all typs of publications | all by year and first author | MUG authors |
** = Publications listed in SCI/SSCI/Pubmed
Full paper/article (Journal)
** Ehall, B; Herbsthofer, L; Obermüller, B; Karacay, C; Bounab, K; Franz, J; El-Heliebi, A; Boulgaropoulos, B; Bonstingl, L; Sallinger, K; Hois, V; Harer, C; Kotzbeck, P; Graier, WF; Schoiswohl, G; Prietl, B; Pieber, TR
Revisiting type 1 diabetes progression in the non-obese diabetic mouse.
Sci Rep. 2026;
Doi: 10.1038/s41598-026-35483-9
PubMed
FullText
FullText_MUG
** Habich, D; Horvath, A; Feldbacher, N; Rebol, L; Nepel, M; Madl, T; Habisch, HJ; Baumann-Durchschein, F; Fürst, S; Plank, J; Rainer, F; Spindelböck, W; Stauber, RE; Tatscher, E; Wagner, M; Zollner, G; Stadlbauer, V
An observational study on the effect of l-ornithine-l-aspartate (LOLA) on the gut microbiome in liver cirrhosis. A single center phase 4 study.
Clin Nutr. 2026; 56: 106522
Doi: 10.1016/j.clnu.2025.11.007
Web of Science
PubMed
FullText
FullText_MUG
** Haller, R; Hazia, O; Feldbacher, N; Traub, J; Madl, T; Habisch, H; Horvath, A; Stadlbauer, V
Nitrogen recycling by the gut microbiome in sarcopenia
FRONT MICROBIOL. 2026; 16: 1698437
Doi: 10.3389/fmicb.2025.1698437
Web of Science
FullText
FullText_MUG
** Woltsche, J; Pacher-Deutsch, C; Fürst, S; Gulden, L; Schwarzl, J; Feldbacher, N; Nepel, M; Celcer, L; Hasl, N; Rieper, V; Stadlbauer, V; Horvath, A
Microbial Dysbiosis in the Urinary Microbiome of Patients with Cirrhosis.
Am J Gastroenterol. 2026;
Doi: 10.14309/ajg.0000000000003634
Web of Science
PubMed
FullText
FullText_MUG
Short report/Letter
** Ramirez-Obermayer, A; Tripolt, NJ; Pferschy, PN; Kojzar, H; Azhar, K; Aziz, F; Müller, A; Sourij, C; Obermayer-Pietsch, B; Žukauskaitė, K; Horvath, A; Stadlbauer, V; Vajda, C; Fazekas, C; Leal, Garcia, S; Wagner-Skacel, J; Sourij, H
Impact of intermittent fasting on self-regulatory behaviour and sleep in participants with insulin-treated type 2 diabetes: A secondary analysis of the INTERFAST-2 randomised controlled trial.
Diabetes Obes Metab. 2026;
Doi: 10.1111/dom.70469
Web of Science
PubMed
FullText
FullText_MUG
Review
** Spiró, Z; El-Heliebi, A; Mair, MJ; Pieber, TR; Prietl, B; Spiegl-Kreinecker, S; Stanzer, S; Wöhrer, A; Preusser, M; Berghoff, AS
Ex vivo drug screening on patient-derived tumor material to advance functional precision in oncology: an overview on current approaches and unresolved challenges.
Cancer Treat Rev. 2025; 143: 103072
Doi: 10.1016/j.ctrv.2025.103072
Web of Science
PubMed
FullText
FullText_MUG